Tag: investment
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
Touch Sensor Developer Gains $12M in Early Funds
A company making gloves that transmit a sense of touch in games and commercial robotics is raising $12 million in its first venture funding round.
-
Duke Univ Forms Drug Development Company
Duke University and life science investor Deerfield Management are forming a new enterprise to develop drug candidates through early development stages.
-
Report – U.S. Needs Regional Technology Centers
Growth patterns in the U.S. show a concentration of technology development in a few cities, with new policies and investments needed to encourage innovation elsewhere.
-
Radiology A.I. Company Raises $4M in Seed Funds
A start-up company developing systems with artificial intelligence to aid the work of radiologists is raising $4 million in its seed funding round.
-
Cell, Gene Therapy R&D/Mfring Center in Works
A consortium of companies, universities, and hospitals are creating an innovation and manufacturing center in the Boston area for cell and gene therapies.
-
Medical Knowledge A.I. Company Raises Early $4.8M
A company developing a system with artificial intelligence to analyze medical literature for treatment insights is raising nearly $5 million in its first venture round.
-
Institute Invests in Elderly Care Start-Up
Regenstrief Institute, affiliated with Indiana University, is investing in a new company aiming to improve long-term care for older individuals.
-
Infographic – Q3 A.I. Health Investments Set Record
Venture capital funding for companies worldwide building artificial intelligence solutions in health care set new highs in the third quarter of 2019.
-
Engineered Organ Transplant Company Raises New Funds
An enterprise that applies gene editing to create replacement organs from pigs for human transplant is raising $100 million in new venture financing.